|
INTS8 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.95250000296122E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.522720E-03 |
| Normal-vs-Stage2 |
8.986000E-04 |
| Normal-vs-Stage3 |
5.55629999999807E-05 |
| Normal-vs-Stage4 |
7.901200E-03 |
| Stage1-vs-Stage2 |
6.104300E-02 |
| Stage1-vs-Stage3 |
1.299070E-03 |
| Stage1-vs-Stage4 |
2.276800E-03 |
| Stage2-vs-Stage3 |
4.252400E-01 |
| Stage2-vs-Stage4 |
1.814800E-01 |
| Stage3-vs-Stage4 |
4.806200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.48369999958464E-07 |
| Normal-vs-AfricanAmerican |
2.777200E-04 |
| Normal-vs-Asian |
1.320040E-02 |
| Caucasian-vs-AfricanAmerican |
5.923200E-01 |
| Caucasian-vs-Asian |
9.137800E-02 |
| AfricanAmerican-vs-Asian |
2.406500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.1997999999912E-05 |
| Normal-vs-Female |
1.93939999615367E-08 |
| Male-vs-Female |
1.842600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.264540E-03 |
| Normal-vs-Extreme_Weight |
1.641880E-03 |
| Normal-vs-Obese |
2.17579999994832E-06 |
| Normal-vs-Extreme_Obese |
5.514200E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.144600E-01 |
| Normal_Weight-vs-Obese |
3.621800E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.180200E-01 |
| Extreme_Weight-vs-Obese |
4.692200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.805000E-01 |
| Obese-vs-Extreme_Obese |
7.960200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.416100E-04 |
| Normal-vs-Age(41-60Yrs) |
3.68229999825331E-08 |
| Normal-vs-Age(61-80Yrs) |
4.222300E-04 |
| Normal-vs-Age(81-100Yrs) |
2.994000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.097600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.955200E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.741570E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.306400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.692010E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.385000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.5313799999972E-05 |
| Normal-VS-Type2 PRCC |
5.322400E-03 |
| Normal-VS-KIRP CIMP |
1.82082999999889E-05 |
| Normal-VS-Unclassified PRCC |
4.539500E-03 |
| Type1 PRCC-VS-Type2 PRCC |
3.852000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.63929999999324E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
6.446400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.92689999999329E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
3.190400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.858140E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.162280E-03 |
| Normal-vs-N1 |
4.248699999998E-05 |
| Normal-vs-N2 |
3.7582000000036E-05 |
| N0-vs-N1 |
1.396420E-03 |
| N0-vs-N2 |
8.398500E-02 |
| N1-vs-N2 |
5.076200E-01 |
|
|
